Tweets
This graph is a reminder that over time, the level of Inflammation in RA may reduce with lower symptoms. However, CUMULATIVE inflam leads to increasing damage & disability #EULAR2019 https://t.co/ujhODMOp4E
Dr Irwin Lim @_connectedcare ( View Tweet )
7 years 1 month ago
Look at the difference in patient reported outcome measures. Baracitinib vs Adalimumab #EULAR2019 https://t.co/xrQDdKIspV
Dr Irwin Lim @_connectedcare ( View Tweet )
7 years 1 month ago
Risk factors for #sarcopenia in #rheumatoid arthritis
👉🏼Male
👉🏼Old age
👉🏼Glucocorticoid
👉🏼Increased MMP3
👉🏼Increased HAQ
#EULAR2019 THU0159
#muscle #RheumatoidArthritis https://t.co/Fn1SvCapqm
Dr Ai Lyn Tan @DrAiLynTan ( View Tweet )
7 years 1 month ago
patients are lucky to have docs like @DrHillaryNorton sharing these #arthritis #breakthroughs #EULAR2019 https://t.co/nQg1WIFD4c
CreakyJoints.org @CreakyJoints ( View Tweet )
7 years 1 month ago
Optimizing
➡️#weight
➡️sleep
➡️physical #health
➡️emotional health
➡️MTX use
👉🏼may improve persistent #fatigue beyond control of #rheumatoid inflammation
via @Susanbartlett12 #EULAR2019
#obesity https://t.co/vuMNWazloo
Dr Ai Lyn Tan @DrAiLynTan ( View Tweet )
7 years 1 month ago
TNF inhibitors vs JAK inhibitors: what’s the head-to-head study state of play?
(**efficacy not safety, non-real life data of course)
#EULAR2019 Gerd Burmester on ‘The wind of change in RA’ @RheumNow https://t.co/zK1wqskmLc
David Liew @drdavidliew ( View Tweet )
7 years 1 month ago
AE in SENCIS data. #EULAR2019 Ofev had higher discontinuation due to medication and higher GI associated illness in the trial. https://t.co/0E21Z4B8TU
Dr. Dinesh Khanna @sclerodermaUM ( View Tweet )
7 years 1 month ago
MAXIMISE: rct of secukinumab on axial manifestations of PsA #EULAR2019
Positive as we would expect https://t.co/I1GfxlfWuX
Dr Irwin Lim @_connectedcare ( View Tweet )
7 years 1 month ago
Burmester on combining TNFi and JAK inhibitors in RA: “I have approached... even companies with both a TNF inhibitor and a JAK inhibitor. I have failed”. Wouldn’t it be interesting to see some data on this? #EULAR2019 @RheumNow
David Liew @drdavidliew ( View Tweet )
7 years 1 month ago
Solid tumors outcomes in patients with RA treated with #Abatacept - no increase in risk 5.2k in patients over 10years Dra. Teresa Simon #EULAR2019 https://t.co/BIA90SH7qc
Dr.Martínez @MtzReuma ( View Tweet )
7 years 1 month ago
I am also a big fan of BPs for their durability of treatment effect https://t.co/DKNYboSjdA
Dr Philip Robinson @philipcrobinson ( View Tweet )
7 years 1 month ago
Gerd Burmester raising some interesting practical questions regarding the use of #biosimilars at #EULAR2019:
How many drugs can a rheumatologist memorize?
How much information material et.c can a rheumatologist store?
How to avoid the ‘#nocebo’ effect when switching?
NatRevRheumatol @NatRevRheumatol ( View Tweet )
7 years 1 month ago
Cool App called SSDM made by Shanghai group using patient reported data aligned with SLEDAI questions to facilitate pt care, and frequent use of the app correlates well with the attainment of #LLDAS #eular2019 @RheumNow
Alberta Hoi @tuna0sashimi ( View Tweet )
7 years 1 month ago
Nice work by Mohammad Derakhshan from @iiiglasgow @UofGMVLS https://t.co/ZsCQ5DtAz1
Stefan Siebert @StefanSiebert1 ( View Tweet )
7 years 1 month ago
In the largest-ever #cohort of inflammatory disease #offspring, very few serious infections in children exposed to #non-TNFi biologics or #tofacitinib were detected #EULAR2019 @carmona_loreto https://t.co/xxbNb5Q2mq
ARD & RMD Open @ARD_BMJ ( View Tweet )
7 years 1 month ago
